Product Overview: Exforge
Exforge 5mg/160mg Novartis is a dual-component pharmaceutical formulation combining amlodipine besylate (5mg) and valsartan (160mg) in a single tablet format. This fixed-dose combination represents a well-established approach to cardiovascular pharmacology research, allowing investigators to examine the synergistic mechanisms of calcium channel blockade and angiotensin receptor antagonism. As part of our comprehensive collection available through Stroid UK Shop, this formulation provides researchers with access to pharmaceutical-grade compounds for controlled laboratory investigations. The dual-mechanism design enables studies examining how combined calcium channel and renin-angiotensin system modulation affects vascular function in experimental models.
Laboratory Applications
This combination formulation serves multiple research purposes in cardiovascular and renal physiology studies. Researchers can investigate the pharmacokinetic interactions between amlodipine’s dihydropyridine calcium channel blocking activity and valsartan’s selective AT1 receptor antagonism. The fixed-dose nature allows for simplified dosing protocols in animal models while maintaining consistent ratios between the active components. Investigators studying hypertension mechanisms often utilise this formulation alongside other compounds from our miscellaneous research compounds category. The combination provides insights into additive antihypertensive effects that cannot be achieved through single-agent studies. Additionally, researchers examining endothelial function, arterial compliance, and renal hemodynamics find this dual-component system valuable for mechanistic investigations.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Components | Amlodipine besylate 5mg + Valsartan 160mg |
| Formulation | Fixed-dose combination tablet |
| Manufacturer | Novartis |
| Storage | Room temperature, dry conditions |
| Molecular Formula (Amlodipine) | C₂₀H₂₅ClN₂O₅ |
| Molecular Formula (Valsartan) | C₂₄H₂₉N₅O₃ |
The pharmaceutical-grade quality ensures consistent results across experimental protocols. Researchers working with cardiovascular compounds often cross-reference studies involving SARMs and peptides to understand comprehensive physiological interactions in controlled laboratory environments.
Research Compliance
This product is intended strictly for in-vitro laboratory research and educational purposes only. Not approved for human consumption, therapeutic use, or any application outside controlled scientific investigation. Researchers must follow institutional guidelines and safety protocols when handling pharmaceutical compounds. All studies should be conducted under appropriate laboratory conditions with proper documentation and adherence to relevant research ethics standards.
